Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation.

Citation data:

Nuclear medicine and biology, ISSN: 1872-9614, Vol: 39, Issue: 1, Page: 101-7

Publication Year:
2012
Usage 27
Abstract Views 25
Link-outs 2
Captures 36
Exports-Saves 27
Readers 9
Citations 9
Citation Indexes 9
Repository URL:
https://escholarship.umassmed.edu/radiology_pubs/43
PMID:
21958854
DOI:
10.1016/j.nucmedbio.2011.06.006
Author(s):
Liu, Yuxia; Cheng, Dengfeng; Liu, Xinrong; Liu, Guozheng; Dou, Shuping; Xiao, Nan; Chen, Ling; Rusckowski, Mary; Hnatowich, Donald J.
Publisher(s):
Elsevier BV
Tags:
Biochemistry, Genetics and Molecular Biology; Medicine; Nanoparticle; Antisense oligomer; Herceptin; Streptavidin; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biotin; Cell Line, Tumor; Drug Delivery Systems; Flow Cytometry; Humans; Indicators and Reagents; Indium Radioisotopes; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Streptavidin; Vitamin B Complex; Cancer Biology; Medicinal-Pharmaceutical Chemistry; Nanomedicine; Oncology; Radiochemistry; Radiology
article description
Auger radiotherapy requires adequate tumor delivery and high nuclear accumulation and retention. We hypothesize that the noncovalent nature of a streptavidin/biotin three-component nanoparticle possessing these qualities may be required for dissociation of the radiolabeled oligomer and its accumulation into the cell nucleus.